Human Papillomavirus Type 16 Viral Load Is Higher in Human Immunodeficiency Virus-Seropositive Women with High-Grade Squamous Intraepithelial Lesions Than in Those with Normal Cytology Smears

Journal of Clinical Microbiology

Volumn 42, Issue 5, 2004, Pages 2212-2215

  Lefevre, Jonas ^a,b   Hankins, Catherine ^c,d   Money, Deborah ^e   Rachlis, Anita ^f   Pourreaux, Karina ^d   Coutlée, François ^a,b,g  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA;

AGE; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; WART VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 2442604522     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.5.2212-2215.2004     Document Type: Article

References (19)

1. Coutlée, F., C. Hankins, N. Lapointe, J. Gill, B. Romanowski, S. Shafran, R. Grimshaw, D. Haase, W. Schlech, J. Sellors, F. Smaill, M. Boucher, M. Chateauvert, J. Falutz, R. Lalonde, J. Macleod, G. Noel, J. P. Routy, E. Toma, G. Garber, G. Victor, S. Trottier, P. Berger, L. Friedland, and D. Keystone. 1997. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. J. Med. Virol. 51:42-47.
2. de Sanjose, S., and J. Palefsky. 2002. Cervical and anal HPV infections in HIV positive women and men. Virus Res. 89:201-211.
3. Hankins, C., F. Coutlee, N. Lapointe, P. Simard, T. Tran, J. Samson, L. Hum, and The Canadian Women's HIV Study Group. 1999. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can. Med. Assoc. J. 160:185-191.
4. Josefsson, A. M., P. K. E. Magnusson, N. Ylitalo, P. Sorensen, P. Qwarforth-Tubbin, P. K. Anderson, M. Melbye, H. O. Adami, and U. B. Gyllensten. 2000. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355:2189-2193.
5. Klein, R. S., G. Y. F. Ho, S. H. Vermund, I. Fleming, and R. D. Burk. 1994. Risk factors for squamous intraepithelial lesions on pap smear in women at risk for human immunodeficiency virus infection. J. Infect. Dis. 170:404-409.
6. Lefevre, J., C. Hankins, K. Pourreaux, The Canadian Women's HIV Study Group, and F. Coutlée. 2004. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J. Med. Virol. 72:132-137.
7. Lefevre, J., C. Hankins, K. Pourreaux, H. Voyer, The Canadian Women's HIV Study Group, and F. Coutlée. 2003. Internal controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. J. Virol. Methods 114:135-144.
8. Lorincz, A. T., P. E. Castle, M. E. Sherman, D. R. Scott, A. G. Glass, S. Wacholder, B. B. Rush, P. E. Gravitt, J. E. Schussler, and M. Schiffman. 2002. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360:228-229.
9. Moscicki, A. B., J. H. Ellenberg, S. H. Vermund, C. A. Holland, T. Darragh, P. A. Crowley-Nowick, L. Levin, and C. M. Wilson. 2000. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls-impact of infection with human immunodeficiency virus. Arch. Pediatr. Adolescent Med. 154:127-134.
10. Schlecht, N. F., A. Trevisan, E. Duarte-Franco, T. E. Rohan, A. Ferenczy, Villa, L. L., and E. L. Franco. 2003. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer 103:519-524.
11. Serwadda, D., M. J. Wawer, K. V. Shah, N. K. Sewankambo, R. Daniel, C. Li, A. Lorincz, M. P. Meehan, F. Wabwire-Mangen, and R. H. Gray. 1999. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J. Infect. Dis. 180:1316-1319.
12. Shah, K. V., L. Solomon, R. Daniel, S. Cohn, and D. Vlahov. 1997. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J. Clin. Microbiol. 35:517-519.
13. Sun, X. W., A. Ferenczy, D. Johnson, J. P. Koulos, O. Lungu, R. M. Richart, and T. C. Wright, Jr. 1995. Evaluation of the hybrid capture human papillomavirus deoxyribonucleic acid detection test. Am. J. Obstet. Gynecol. 173:1432-1437.
14. Swan, D. C., R. A. Tucker, G. Tortolero-Luna, M. F. Mitchell, L. Wideroff, E. R. Unger, R. A. Nisenbaum, W. C. Reeves, and J. P. Icenogle. 1999. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J. Clin. Microbiol. 37:1030-1034.
15. van Duin, M., P. J. F. Snijders, H. F. J. Schrijnemakers, F. J. Voorhorst, L. Rozendaal, M. A. E. Nobbenhuis, A. J. C. van den Brule, R. H. M. Verheijen, T. J. Helmerhorst, and C. J. L. M. Meijer. 2002. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int. J. Cancer 98:590-595.
16. Vernon, S. D., W. C. Reeves, K. A. Clancy, M. Laga, M. St. Louis, H. E. Gary, R. W. Ryder, A. T. Manoka, and J. P. Icenogle. 1994. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women. J. Infect. Dis. 169:1108-1112.
17. Weissenborn, S. J., A. M. Funke, M. Hellmich, P. Mallmann, P. G. Fuschs, H. J. Pfister, and U. Wieland. 2003. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J. Clin. Microbiol. 41:2763-2767.
18. Womack, S. D., Z. M. Chirenje, L. Gaffikin, P. D. Blumenthal, J. A. McGrath, T. Chipato, S. Ngwalle, M. Munjoma, and K. V. Shah. 2000. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int. J. Cancer 85:206-210.
19. Ylitalo, N., P. Sorensen, A. M. Josefsson, P. K. E. Magnusson, P. K. Anderson, J. Ponten, H. O. Adami, U. B. Gyllensten, and M. Melbye. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198.